MAPT and Alzheimer disease: They suggest that reactive astrocytosis, an established biological response to neuronal injury (41, 46) may be an early initiator of AD pathogenesis, preceding brain amyloid accumulation, tau deposition, neurodegeneration and the onset of cognitive impairment in patients who eventually develop AD.